Efficacy And Safety Of The Elexacaftor Plus Tezacaftor Plus Ivacaftor Combination Regimen In People With Cystic Fibrosis Homozygous For The F508del Mutation: A Double-Blind, Randomised, Phase 3 Trial (Vol 394, Pg 1940, 2019)